際際滷

際際滷Share a Scribd company logo
Ocular manifestations of HIV
INTRODUCTION
( incidence & virology)
ETIOPATHOGENISIS
History
 1st reported on June 5, 1981 when the U.S
Centers for Disease Control recorded a cluster
of Pneumocystis carinii pneumonia in five
homosexual men in Los Angeles
 Its cause HIV was identified in the early 1980s
2
 Human immunodeficiency virus (HIV) is a blood-
borne, sexually transmissible virus.
Global prevalence
 In 2014, WHO estimated 33.4 million people
worldwide living with HIV/AIDS,
 with 2.7 million new cases of HIV infection per
year
 and 2.0 million deaths due to AIDS
4
 According to UNAIDS report, 60 million people
have been infected since the start of
pandemic , with 25 million deaths, and 14
million orphaned children in southern Africa
alone
5
introduction to HIV
NACO 2015
Classification of HIV
 Two serological types
 HIV  1 (world wide)
 HIV  2 (West Africa & Portugal)
 HIV  1  HIV  2
1.Type M 1. Type A, B,C,D and E
2. Type O
8
 HIV is a member of the genus Lentivirus, part of
the family Retroviridae .
 it is composed of two copies of positive single-
stranded RNA
 the single-stranded RNA is tightly bound to
nucleocapsid proteins, p7, and enzymes needed
for the development of the virion such as reverse
transcriptase, proteases, ribonuclease and integra
se.
 the viral envelope contains proteins from the
host cell and relatively few copies of the HIV
Envelope protein, which consists of a cap
made of three molecules known
as glycoprotein (gp) 120,
Type 1
 HIV-1 probably originated from one or more
cross-species transfers from chimpanzees in
central Africa.
 HIV-2 is closely related to viruses that infect
sooty mangabeys in western Africa.
 Genetically, HIV-1 and HIV-2 are superficially
similar, but each contains unique genes and its
own distinct replication process.
Type 2
 HIV-2 carries a slightly lower risk of transmission, and HIV-2
infection tends to progress more slowly to acquired immune
deficiency syndrome (AIDS).
 This may be due to a less-aggressive infection rather than a
specific property of the virus itself.
 Persons infected with HIV-2 tend to have a lower viral load
than people with HIV-1, and a greater viral load is associated
with more rapid progression to AIDS in HIV-1 infections
 HIV-2 is rare in the developed world. Consequently, most of
the research and vaccine and drug development has been
(perhaps unfairly) focused on HIV-1
introduction to HIV
etiopathogenesis
 Mode of infection
HIV Transmission
Requires:
1. Infected body fluid
AND
2. Entry into body
Mode of transmission
 Sexual contact  70% of cases
 IV drug use  27%
 Blood transfusion  2-3%
 Perinatal transmission  1%
16
3. Infected body fluids
Four Fluids, if infected, can transmit HIV
a. Blood
b. Semen
c. Vaginal Secretions
d. Breast Milk
If these enter the body
4. Which Fluids are safe?
Four Fluids that cant transmit HIV
a. Spit/saliva
b. Pee/Urine
c. Sweat
d. Tears
How Does HIV get into a T Cell?
1. attaches to infection fighting T4 cell
2. Locks on to two entry areas of the T4 cell
at once. (Keys in lock)
3. Tricks T4 cell to allow Virus RNA to enter
What Does HIV do inside a T Cell?
1. Viruss RNA changes into
DNA
2. Enters Cell nucleus &
becomes part of Hosts
DNA!
3. Programs T cell to produce
virus in abundance
4. New viruses bud off Host T
cell, killing T cell, & enters
bloodstream
5. New HIV viruses infect more
T cells
Flowchart
Binding to CD4 Internalization Uncoating
Reverse transcriptase
Integrated proviral DNA
Productive infection Latent infection
Mature HIV production
Cell lysis
21
New HIV viruses leaving a cell
Pathophysiology
 HIV attaches to T-cells & monocytes
/macrophage that display a membrane Ag-
complex known as CD4.
 The target cells of HIV show different cytopathic
effects
 CD4 + helper T-cells  decrease in number 
immunodef.  opportunistic infections
23
* Macrophage 
> decreased migration response to
chemoattractants
> defective intracellular killing of mircroorg.
(eg. Toxo. , Candida.)
> impaired Ag presentation
*excessive production of TNF-alpha leads to
dementia , wasting , unexplained fever.
6. What is the Window Period?
The time period between a persons exposure
& actual infection with HIV and until antibodies
are detectable in the body.
 After three months there are usually enough
antibodies to show on an AIDS test.
Nearly all people (99%) develop antibodies by
THREE months.
 Th pressence of any two major signs
associated with atleast one minor sign is
considered to be an indiaction of AIDS
Major signs include
 Loss of more than 10% of body weight
 Chronic fever
 Chronic diarrhoea of over 1 months duration
Minor signs include
 Chronic cough
 Itchy dermatitis
 Recurrent herpese zoster
 Oropharyngeal candidiasis
 Chronic progressive herpes simplex infection
 Generalised lymphadenopathy
 Eye involvement seen in 90% Autopsy cases
 Ocular complication in 75% of pts with AIDS
 Visual morbidity & blindness is the leading
cause of suicide in pt. with AIDS
 May be the first sign of HIV infection this shows
the Role of Eye consultant to make a sight
saving & life sustaining Diagnosis
29
To be continued

More Related Content

What's hot (20)

Arbo viruses
Arbo virusesArbo viruses
Arbo viruses
Dr.Dinesh Jain
Viral Hemorrhagic Fevers
Viral Hemorrhagic FeversViral Hemorrhagic Fevers
Viral Hemorrhagic Fevers
Mostafa Mahmoud
DNA Viruses - Microbiology
DNA Viruses - MicrobiologyDNA Viruses - Microbiology
DNA Viruses - Microbiology
School of Biosciences, MACFAST College, Tiruvalla, Kerala, India
Comprehensive Presentation on HIV/AIDS
Comprehensive Presentation on HIV/AIDSComprehensive Presentation on HIV/AIDS
Comprehensive Presentation on HIV/AIDS
Reynel Dan
Introduction to infectious diseases
Introduction to infectious diseasesIntroduction to infectious diseases
Introduction to infectious diseases
Dr. Majid Mohiuddin (Hashmi)
Human immunodeficiency virus(hiv)
Human immunodeficiency virus(hiv)Human immunodeficiency virus(hiv)
Human immunodeficiency virus(hiv)
Shasidhar Reddy
Hepatitis viruses
Hepatitis virusesHepatitis viruses
Hepatitis viruses
Tarek Mahbub Khan
Corona virus infection
Corona virus infectionCorona virus infection
Corona virus infection
Gamal Agmy
CORONA VIRUS - COVID 19
CORONA VIRUS - COVID 19CORONA VIRUS - COVID 19
CORONA VIRUS - COVID 19
Dr.Hashim Syed Ali (Dr.Foster)
HIV/AIDS AWARENESS PREVENTION TREATMENT & SERVICE
HIV/AIDS AWARENESS PREVENTION TREATMENT & SERVICEHIV/AIDS AWARENESS PREVENTION TREATMENT & SERVICE
HIV/AIDS AWARENESS PREVENTION TREATMENT & SERVICE
sukhadevsinghadiya
HIV - Human Immunodeficiency Virus
HIV - Human Immunodeficiency VirusHIV - Human Immunodeficiency Virus
HIV - Human Immunodeficiency Virus
Meenatchisundaram Subramani
Aids presentation
Aids presentationAids presentation
Aids presentation
angelvizzu
Microbiology of HIV VIRUSES
Microbiology of HIV VIRUSESMicrobiology of HIV VIRUSES
Microbiology of HIV VIRUSES
Guilherme Paschoalini
Medical Microbiology Laboratory (sample collection)
Medical Microbiology Laboratory (sample collection)Medical Microbiology Laboratory (sample collection)
Medical Microbiology Laboratory (sample collection)
Hussein Al-tameemi
Malaria
MalariaMalaria
Malaria
Shanyar Hama Karim
Influenza virus
Influenza virus Influenza virus
Influenza virus
microbiology Notes
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
DrAmrita Rastogi
General properties of viruses
General properties of virusesGeneral properties of viruses
General properties of viruses
raghunathp
Salmonella
SalmonellaSalmonella
Salmonella
prakashtu
HIV
HIVHIV
HIV
Awaaz Batazoo

Similar to introduction to HIV (20)

The ear anatomy and physiology
The ear anatomy and physiology The ear anatomy and physiology
The ear anatomy and physiology
MuniraMkamba
HIV (AIDS)
 HIV (AIDS) HIV (AIDS)
HIV (AIDS)
sakhawat sajib
HUMAN IMMUNODEFICIENCY VIRUS INFECTION.pptx
HUMAN IMMUNODEFICIENCY VIRUS INFECTION.pptxHUMAN IMMUNODEFICIENCY VIRUS INFECTION.pptx
HUMAN IMMUNODEFICIENCY VIRUS INFECTION.pptx
Dr Priyanka Dabas
HIV infection&AIDS 023.ppt
HIV infection&AIDS 023.pptHIV infection&AIDS 023.ppt
HIV infection&AIDS 023.ppt
japhetPeter1
(AIDS).ppt
(AIDS).ppt(AIDS).ppt
(AIDS).ppt
Fridahchungu
HIV pathology sufia husain 2017
HIV pathology sufia husain 2017HIV pathology sufia husain 2017
HIV pathology sufia husain 2017
Sufia Husain
PPT HIV SLY.pptx
PPT HIV SLY.pptxPPT HIV SLY.pptx
PPT HIV SLY.pptx
SylvesterAdesue1
HIV-AIDS.ppt for the community health nursing
HIV-AIDS.ppt for the community health nursingHIV-AIDS.ppt for the community health nursing
HIV-AIDS.ppt for the community health nursing
faheembasharat593
Hiv & pregnancy
Hiv & pregnancyHiv & pregnancy
Hiv & pregnancy
Mesfin Mulugeta
HIV/AIDS (IMMUNOLOGY)
HIV/AIDS (IMMUNOLOGY)HIV/AIDS (IMMUNOLOGY)
HIV/AIDS (IMMUNOLOGY)
Kemie Ogunbayode
Hiv aids seminar communti
Hiv aids seminar communtiHiv aids seminar communti
Hiv aids seminar communti
Bassam Daqaq
Hiv infection-and-aids dr bikal
Hiv infection-and-aids dr bikalHiv infection-and-aids dr bikal
Hiv infection-and-aids dr bikal
Bikal Lamichhane
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
Jayaramachandran S
Hiv
HivHiv
Hiv
riski albughari
Unit 16 HIV-AIDS (1).pptx
Unit 16 HIV-AIDS (1).pptxUnit 16 HIV-AIDS (1).pptx
Unit 16 HIV-AIDS (1).pptx
BarentuShemsu
HIV - A Brief History
HIV - A Brief HistoryHIV - A Brief History
HIV - A Brief History
Eyal Kalmar
Hiv
HivHiv
Hiv
chindo mallum
Communicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDSCommunicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDS
Ralph Bawalan
Hiv infection
Hiv infectionHiv infection
Hiv infection
NANDEENIPAREKH
HIV Introduction and Epidemiology.ppt,,,
HIV Introduction and Epidemiology.ppt,,,HIV Introduction and Epidemiology.ppt,,,
HIV Introduction and Epidemiology.ppt,,,
fredyyohana
The ear anatomy and physiology
The ear anatomy and physiology The ear anatomy and physiology
The ear anatomy and physiology
MuniraMkamba
HUMAN IMMUNODEFICIENCY VIRUS INFECTION.pptx
HUMAN IMMUNODEFICIENCY VIRUS INFECTION.pptxHUMAN IMMUNODEFICIENCY VIRUS INFECTION.pptx
HUMAN IMMUNODEFICIENCY VIRUS INFECTION.pptx
Dr Priyanka Dabas
HIV infection&AIDS 023.ppt
HIV infection&AIDS 023.pptHIV infection&AIDS 023.ppt
HIV infection&AIDS 023.ppt
japhetPeter1
HIV pathology sufia husain 2017
HIV pathology sufia husain 2017HIV pathology sufia husain 2017
HIV pathology sufia husain 2017
Sufia Husain
HIV-AIDS.ppt for the community health nursing
HIV-AIDS.ppt for the community health nursingHIV-AIDS.ppt for the community health nursing
HIV-AIDS.ppt for the community health nursing
faheembasharat593
Hiv aids seminar communti
Hiv aids seminar communtiHiv aids seminar communti
Hiv aids seminar communti
Bassam Daqaq
Hiv infection-and-aids dr bikal
Hiv infection-and-aids dr bikalHiv infection-and-aids dr bikal
Hiv infection-and-aids dr bikal
Bikal Lamichhane
Unit 16 HIV-AIDS (1).pptx
Unit 16 HIV-AIDS (1).pptxUnit 16 HIV-AIDS (1).pptx
Unit 16 HIV-AIDS (1).pptx
BarentuShemsu
HIV - A Brief History
HIV - A Brief HistoryHIV - A Brief History
HIV - A Brief History
Eyal Kalmar
Communicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDSCommunicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDS
Ralph Bawalan
HIV Introduction and Epidemiology.ppt,,,
HIV Introduction and Epidemiology.ppt,,,HIV Introduction and Epidemiology.ppt,,,
HIV Introduction and Epidemiology.ppt,,,
fredyyohana

Recently uploaded (20)

psychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy managementpsychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy management
Dr Shiksha Verma (PT)
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Rehab Aboshama
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
Dr. Anindya
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
The influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcomeThe influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcome
Lokesh Kumar Sharma
patho neuro block 3 QUESTION AANSWER PDF
patho neuro block 3 QUESTION AANSWER PDFpatho neuro block 3 QUESTION AANSWER PDF
patho neuro block 3 QUESTION AANSWER PDF
HariPrashadL
FAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptxFAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptx
Wahid Husein
Eye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptxEye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptx
KafrELShiekh University
bacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptxbacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptx
Dauda Yahaya masani
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptxRabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Wahid Husein
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management ProtocolDiabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Dr Anik Roy Chowdhury
MLS 208 - UNIT 4 A - Tissue Processing - ETANDO AYUK - SANU 1 - Secured.pdf
MLS 208 -  UNIT  4 A  -  Tissue Processing  - ETANDO AYUK - SANU 1 - Secured.pdfMLS 208 -  UNIT  4 A  -  Tissue Processing  - ETANDO AYUK - SANU 1 - Secured.pdf
MLS 208 - UNIT 4 A - Tissue Processing - ETANDO AYUK - SANU 1 - Secured.pdf
Eswatini Medical Christian University - EMCU / Southern Nazarene University - SANU
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
zilkerapurbo
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxBIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
drnidhimnd
ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
Biography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo GiordanoBiography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo Giordano
Dr. Vincenzo Giordano
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
KHUSHAL CHAVAN
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptxphysiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
amralmohammady27
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
legal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptxlegal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptx
Rishika Rawat
psychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy managementpsychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy management
Dr Shiksha Verma (PT)
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Rehab Aboshama
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
Dr. Anindya
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
The influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcomeThe influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcome
Lokesh Kumar Sharma
patho neuro block 3 QUESTION AANSWER PDF
patho neuro block 3 QUESTION AANSWER PDFpatho neuro block 3 QUESTION AANSWER PDF
patho neuro block 3 QUESTION AANSWER PDF
HariPrashadL
FAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptxFAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptx
Wahid Husein
Eye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptxEye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptx
KafrELShiekh University
bacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptxbacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptx
Dauda Yahaya masani
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptxRabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Wahid Husein
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management ProtocolDiabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Dr Anik Roy Chowdhury
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
zilkerapurbo
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxBIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
drnidhimnd
ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
Biography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo GiordanoBiography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo Giordano
Dr. Vincenzo Giordano
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
KHUSHAL CHAVAN
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptxphysiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
amralmohammady27
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
legal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptxlegal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptx
Rishika Rawat

introduction to HIV

  • 1. Ocular manifestations of HIV INTRODUCTION ( incidence & virology) ETIOPATHOGENISIS
  • 2. History 1st reported on June 5, 1981 when the U.S Centers for Disease Control recorded a cluster of Pneumocystis carinii pneumonia in five homosexual men in Los Angeles Its cause HIV was identified in the early 1980s 2
  • 3. Human immunodeficiency virus (HIV) is a blood- borne, sexually transmissible virus.
  • 4. Global prevalence In 2014, WHO estimated 33.4 million people worldwide living with HIV/AIDS, with 2.7 million new cases of HIV infection per year and 2.0 million deaths due to AIDS 4
  • 5. According to UNAIDS report, 60 million people have been infected since the start of pandemic , with 25 million deaths, and 14 million orphaned children in southern Africa alone 5
  • 8. Classification of HIV Two serological types HIV 1 (world wide) HIV 2 (West Africa & Portugal) HIV 1 HIV 2 1.Type M 1. Type A, B,C,D and E 2. Type O 8
  • 9. HIV is a member of the genus Lentivirus, part of the family Retroviridae . it is composed of two copies of positive single- stranded RNA the single-stranded RNA is tightly bound to nucleocapsid proteins, p7, and enzymes needed for the development of the virion such as reverse transcriptase, proteases, ribonuclease and integra se.
  • 10. the viral envelope contains proteins from the host cell and relatively few copies of the HIV Envelope protein, which consists of a cap made of three molecules known as glycoprotein (gp) 120,
  • 11. Type 1 HIV-1 probably originated from one or more cross-species transfers from chimpanzees in central Africa. HIV-2 is closely related to viruses that infect sooty mangabeys in western Africa. Genetically, HIV-1 and HIV-2 are superficially similar, but each contains unique genes and its own distinct replication process.
  • 12. Type 2 HIV-2 carries a slightly lower risk of transmission, and HIV-2 infection tends to progress more slowly to acquired immune deficiency syndrome (AIDS). This may be due to a less-aggressive infection rather than a specific property of the virus itself. Persons infected with HIV-2 tend to have a lower viral load than people with HIV-1, and a greater viral load is associated with more rapid progression to AIDS in HIV-1 infections HIV-2 is rare in the developed world. Consequently, most of the research and vaccine and drug development has been (perhaps unfairly) focused on HIV-1
  • 15. HIV Transmission Requires: 1. Infected body fluid AND 2. Entry into body
  • 16. Mode of transmission Sexual contact 70% of cases IV drug use 27% Blood transfusion 2-3% Perinatal transmission 1% 16
  • 17. 3. Infected body fluids Four Fluids, if infected, can transmit HIV a. Blood b. Semen c. Vaginal Secretions d. Breast Milk If these enter the body
  • 18. 4. Which Fluids are safe? Four Fluids that cant transmit HIV a. Spit/saliva b. Pee/Urine c. Sweat d. Tears
  • 19. How Does HIV get into a T Cell? 1. attaches to infection fighting T4 cell 2. Locks on to two entry areas of the T4 cell at once. (Keys in lock) 3. Tricks T4 cell to allow Virus RNA to enter
  • 20. What Does HIV do inside a T Cell? 1. Viruss RNA changes into DNA 2. Enters Cell nucleus & becomes part of Hosts DNA! 3. Programs T cell to produce virus in abundance 4. New viruses bud off Host T cell, killing T cell, & enters bloodstream 5. New HIV viruses infect more T cells
  • 21. Flowchart Binding to CD4 Internalization Uncoating Reverse transcriptase Integrated proviral DNA Productive infection Latent infection Mature HIV production Cell lysis 21
  • 22. New HIV viruses leaving a cell
  • 23. Pathophysiology HIV attaches to T-cells & monocytes /macrophage that display a membrane Ag- complex known as CD4. The target cells of HIV show different cytopathic effects CD4 + helper T-cells decrease in number immunodef. opportunistic infections 23
  • 24. * Macrophage > decreased migration response to chemoattractants > defective intracellular killing of mircroorg. (eg. Toxo. , Candida.) > impaired Ag presentation *excessive production of TNF-alpha leads to dementia , wasting , unexplained fever.
  • 25. 6. What is the Window Period? The time period between a persons exposure & actual infection with HIV and until antibodies are detectable in the body. After three months there are usually enough antibodies to show on an AIDS test. Nearly all people (99%) develop antibodies by THREE months.
  • 26. Th pressence of any two major signs associated with atleast one minor sign is considered to be an indiaction of AIDS
  • 27. Major signs include Loss of more than 10% of body weight Chronic fever Chronic diarrhoea of over 1 months duration
  • 28. Minor signs include Chronic cough Itchy dermatitis Recurrent herpese zoster Oropharyngeal candidiasis Chronic progressive herpes simplex infection Generalised lymphadenopathy
  • 29. Eye involvement seen in 90% Autopsy cases Ocular complication in 75% of pts with AIDS Visual morbidity & blindness is the leading cause of suicide in pt. with AIDS May be the first sign of HIV infection this shows the Role of Eye consultant to make a sight saving & life sustaining Diagnosis 29